BACKGROUND: More effective treatments have become available for haematological malignancies from the early 2000s, but few large-scale population-based studies have investigated their effect on survival. Using EUROCARE data, and HAEMACARE morphological groupings, we aimed to estimate time trends in population-based survival for 11 lymphoid and myeloid malignancies in 20 European countries, by region and age. METHODS: In this retrospective observational study, we included patients (aged 15 years and older) diagnosed with haematological malignancies, diagnosed up to Dec 31, 2007, and followed up to Dec 31, 2008. We used data from the 30 cancer registries (across 20 countries) that provided continuous incidence and good quality data from...
Purpose Non-Hodgkin's lymphoma (NHL) is the most common hematologic malignant neoplasm in adults. Mo...
Background Since 2001, the World Health Organization classification of tumours of haematopoietic and...
International audienceBackground Since 2001, the World Health Organization classifi cation of tumour...
Background: More effective treatments have become available for haematological malignancies from the...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
More effective treatments have become available for haematological malignancies from the early 2000s...
Background The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), set u...
The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), set up to impro...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
BACKGROUND: Since 2001, the World Health Organization classification of tumours of haematopoietic an...
BACKGROUND: Since 2001, the World Health Organization classification of tumours of haematopoietic an...
Background: Cancer survival is a key measure of the effectiveness of health-care systems. EUROCARE-t...
Abstract BACKGROUND: Cancer survival is a key measure of the effectiveness of health-care systems. E...
Background Cancer survival is a key measure of the effectiveness of health-care systems. EUROCARE - ...
Purpose Non-Hodgkin's lymphoma (NHL) is the most common hematologic malignant neoplasm in adults. Mo...
Background Since 2001, the World Health Organization classification of tumours of haematopoietic and...
International audienceBackground Since 2001, the World Health Organization classifi cation of tumour...
Background: More effective treatments have become available for haematological malignancies from the...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
More effective treatments have become available for haematological malignancies from the early 2000s...
Background The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), set u...
The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), set up to impro...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
BACKGROUND: Since 2001, the World Health Organization classification of tumours of haematopoietic an...
BACKGROUND: Since 2001, the World Health Organization classification of tumours of haematopoietic an...
Background: Cancer survival is a key measure of the effectiveness of health-care systems. EUROCARE-t...
Abstract BACKGROUND: Cancer survival is a key measure of the effectiveness of health-care systems. E...
Background Cancer survival is a key measure of the effectiveness of health-care systems. EUROCARE - ...
Purpose Non-Hodgkin's lymphoma (NHL) is the most common hematologic malignant neoplasm in adults. Mo...
Background Since 2001, the World Health Organization classification of tumours of haematopoietic and...
International audienceBackground Since 2001, the World Health Organization classifi cation of tumour...